source
- Tiziana Life Sciences CEO Ivor Elrifi boosts stake, buying 321,423 shares at $1 eachTiziana Life Sciences announced that its chief executive officer, Ivor Elrifi, purchased 321,423 common shares of the company on NASDAQ at $1.00 per share. The purchase raises his total holding to…
- Choosing Between CROs and Biotechs: How Company Size Shapes the FitWhile biotechs and contract research organizations each have strengths, the article notes that the right choice depends on a company’s specific situation. Ali Pashazadeh, founder and CEO of Treehi…